Lynn Feys
Overview
Explore the profile of Lynn Feys including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
55
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Feys L, Descamps B, Vanhove C, Vermeulen S, Vandesompele J, Vanderheyden K, et al.
In Vivo
. 2015 Dec;
30(1):1-11.
PMID: 26709122
Background: Bioluminescent cancer models are widely used but detailed quantification of the luciferase signal and functional comparison with a non-transfected control cell line are generally lacking. In the present study,...
2.
Verset L, Feys L, Trepant A, de Wever O, Demetter P
Histol Histopathol
. 2015 Dec;
31(5):469-78.
PMID: 26676939
Four-and-a-half LIM-domain protein 2 (FHL2) is a multifunctional scaffolding protein regulating signalling cascades and gene transcription. It shuttles between focal adhesions and the nucleus where it signals through direct interaction...
3.
Feys L, Descamps B, Vanhove C, Vral A, Veldeman L, Vermeulen S, et al.
Oncotarget
. 2015 Sep;
6(29):26615-32.
PMID: 26396176
Radiotherapy is a mainstay in the postoperative treatment of breast cancer as it reduces the risks of local recurrence and mortality after both conservative surgery and mastectomy. Despite recent efforts...
4.
Jacobs K, Feys L, Vanhoecke B, Van Marck V, Bracke M
Eur J Cancer Prev
. 2011 Mar;
20(3):207-16.
PMID: 21445019
The prognostic discrepancy between localized melanoma and metastatic disease demands a better understanding of melanoma progression. The role of E-cadherin and N-cadherin in melanoma has been widely studied; however, the...